Latest News about VXRT
Recent news which mentions VXRT
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
April 09, 2024
From InvestorPlace
Tickers
VXRT
From InvestorPlace
Earnings Scheduled For March 14, 2024
March 14, 2024
From Benzinga
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 31, 2024
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 31, 2024
From Benzinga
What's Going On With Vaxart Stock Today?
January 17, 2024
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
From Benzinga
What's Going On With Vaxart (VXRT) Stock?
January 16, 2024
From Benzinga
Earnings Scheduled For November 2, 2023
November 02, 2023
From Benzinga
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
October 30, 2023
From Benzinga
From InvestorPlace
3 Biotech Blockbusters to Turn $5,000 Into $50,000
September 12, 2023
From InvestorPlace
Vaxart's Oral Vaccine For Stomach Bug Shows Reduction In Infection Rate
September 07, 2023
Tickers
VXRT
From Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
From Benzinga
Vaxart Touts Encouraging Positive Preliminary Data From Bivalent Norovirus Vaccine Study
July 06, 2023
Tickers
VXRT
From Benzinga
From Benzinga
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 07, 2023
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
Why Is Vaxart (VXRT) Stock Down 25% Today?
June 07, 2023
From InvestorPlace
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
Earnings Scheduled For May 4, 2023
May 04, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.